Is Ozempic a Shot? Everything You Need to Know About the Injection

Last reviewed: June 29, 2026

Last updated: June 29, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Yes, Ozempic is administered as a subcutaneous injection once per week, delivering semaglutide directly under the skin. This delivery method allows the medication to work systematically throughout your body, with peak effect occurring within 1–3 days of injection. PlexusDx provides access to prescription-strength compounded semaglutide injections from licensed 503A pharmacies, making this proven weight loss therapy available in all 50 states without insurance requirements.

How Injectable Semaglutide Works as a GLP-1 Medication

Semaglutide injections replicate a naturally occurring hormone called glucagon-like peptide-1 (GLP-1), which your pancreas normally releases after eating. When you inject semaglutide under the skin, it enters the bloodstream gradually and binds to GLP-1 receptors throughout your brain, gut, and pancreas. This activation triggers three powerful effects: reduced appetite signaling in your hypothalamus, slower stomach emptying so you feel fuller longer, and improved blood sugar control by stimulating insulin release when needed.

Clinical studies demonstrate that injectable semaglutide produces weight loss of 10–15% of body weight over 68 weeks at therapeutic doses. The injection format allows for consistent weekly dosing, which maintains steady hormone levels and maximizes the satiety effect. Because the medication is injected subcutaneously rather than taken orally, it bypasses stomach acid degradation and achieves higher bioavailability—meaning more of the active compound reaches its target receptors compared to oral formulations.

Injection Technique and Administration for Semaglutide

Semaglutide injections are self-administered once weekly using a pre-filled pen or vial with a small 27–29 gauge needle. You inject into fatty tissue on your abdomen, thigh, or upper arm—areas where subcutaneous tissue is accessible and absorption is reliable. The needle length is typically 5–8 mm, which is short enough to minimize discomfort while deep enough to reach the subcutaneous layer. Most patients report that the injection sensation is minimal, comparable to a mosquito bite, and takes less than 10 seconds to complete.

PlexusDx provides detailed injection training and step-by-step written instructions with every shipment of compounded semaglutide. You can rotate injection sites to prevent lipohypertrophy (thickened fat deposits) and ensure consistent absorption week to week. The pre-filled delivery systems eliminate the need to draw doses from a vial, reducing the chance of measurement error and making the process intuitive for patients managing their own care at home.

Why Injection Delivery Outperforms Oral Semaglutide Tablets

Injectable semaglutide achieves 51% greater weight loss compared to oral semaglutide tablets at equivalent dose levels, according to head-to-head clinical trials. This superiority stems from bioavailability: oral tablets must survive stomach acid, pass through the intestinal wall, and cross the liver before reaching systemic circulation. Injections bypass these barriers entirely, delivering the full therapeutic dose directly into your bloodstream where it can immediately reach GLP-1 receptors. The result is faster onset, more sustained hormone levels, and stronger appetite suppression throughout the week.

Additionally, injection-based therapy produces more stable blood glucose control and lower rates of gastrointestinal side effects like nausea compared to oral formulations. Many patients who experience stomach upset with pills find injections much more tolerable. PlexusDx offers both injectable and oral semaglutide options, allowing you to choose the delivery method that aligns with your tolerance and lifestyle—with injection pricing starting at $149 per month regardless of dose strength.

PlexusDx Compounded Semaglutide Injections vs. Branded Ozempic

PlexusDx partners with licensed 503A compounding pharmacies to produce pharmaceutical-grade semaglutide injections formulated to match the strength and purity of brand-name Ozempic. The compounding process creates identical active ingredient molecules in sterile, injectable solutions under strict quality controls. Because compounded medications bypass expensive brand manufacturing and advertising costs, PlexusDx can offer semaglutide injections starting at $149 per month—a fraction of Ozempic's typical $900–$1,200 monthly price. Your dose may need to go up during treatment titration, but your monthly price remains flat.

All PlexusDx semaglutide comes from licensed 503A compounding pharmacies—never 503B facilities—ensuring pharmaceutical-grade quality and compliance with state pharmacy boards. The medication is available in all 50 states with no insurance requirement, no membership fee, and HSA/FSA eligibility. PlexusDx also offers the Precision Peptide Genetic Test ($99 add-on after your first month) to identify your individual GLP-1 receptor variants and other peptide-pathway genes that predict your response, allowing personalized dose optimization from the start.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

Does Ozempic come as an injection or tablet?

Ozempic is exclusively an injectable medication—it does not come as a tablet. The branded product is a once-weekly subcutaneous injection pre-filled in a pen device. PlexusDx offers compounded semaglutide injections with identical active ingredient and delivery mechanism starting at $149 per month through licensed 503A pharmacies nationwide.

How often do you inject semaglutide for weight loss?

Semaglutide is injected once per week, every 7 days, at the same day and time each week. Your healthcare provider will start you at the lowest dose and gradually increase it over 4–5 months (called titration) to minimize side effects while maximizing weight loss. PlexusDx provides a personalized treatment schedule and support throughout your titration phase.

Is compounded semaglutide injection as effective as brand-name Ozempic?

Yes—compounded semaglutide from licensed 503A pharmacies contains the identical active ingredient, same strength, and same injection mechanism as Ozempic. Clinical effectiveness depends on the semaglutide molecule itself, not the manufacturer. PlexusDx uses 503A-compounded injections that meet pharmaceutical-grade standards at a significantly lower cost because they avoid brand markup.

What are the most common side effects of semaglutide injections?

The most frequent side effects during titration are nausea, vomiting, constipation, and diarrhea—most resolve within 2–4 weeks as your body adjusts. Serious side effects are rare but include pancreatitis (severe upper abdominal pain), thyroid inflammation, and gallbladder disease; report any of these immediately to your provider. PlexusDx monitors all patients and provides side effect management guidance throughout treatment.

Can the Precision Peptide Genetic Test predict my semaglutide injection response?

Yes—PlexusDx's Precision Peptide Genetic Test ($99 add-on) analyzes your GLP1R rs6923761 variant and 48 other peptide-pathway genes across 14 metabolic pathways to predict your response strength. Patients with specific GLP1R genotypes show enhanced weight loss with semaglutide injections, allowing PlexusDx to personalize your starting dose and titration timeline based on genetic predisposition rather than trial-and-error.

Related Reading

• Genetic Testing 101 What You Need To Know Before Getting Tested
• Injection Ozempic
• Injection Sites For Ozempic
• Ozempic Injection Sites

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.